<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nichols, Emma Hitt</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Neuzil, Petr</style></author><author><style face="normal" font="default" size="100%">Poole, Jeanne E.</style></author><author><style face="normal" font="default" size="100%">Reddy, Vivek Y.</style></author><author><style face="normal" font="default" size="100%">Klein, Helmut U.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Updates in ICD and CRT Technology</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-11-09 11:22:16</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">11-12</style></pages><abstract><style  face="normal" font="default" size="100%">The development of leadless and subcutaneous implantable cardiac defibrillators and cardiac resynchronization therapy may improve safety of these therapies by utilizing less invasive procedures and reducing infection rates. In addition, wearable cardiac defibrillators can provide protection for certain patient populations, including those who are awaiting implantation or require implantable cardiac defibrillator removal.</style></abstract><number><style face="normal" font="default" size="100%">28 suppl 2</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>